Feline herpesvirus type 1 (FHV-1), a member of the subfamily Alphaherpesvirinae of the family Herpesviridae, causes an upper respiratory tract disease in cats known as feline viral rhinotracheitis. In particular, infections of newborn or debilitated cats with FHV-1 can result in severe generalized disease with high mortality rates (29) . However, the genomic analysis of FHV-1 lags behind those of other herpesviruses, and only four genes encoding FHV-1 gB, gH, and gD (gp60) homologs and thymidine kinase have been identified (19-21, 26, 35) .
To date, many serological comparisons have been made by virus-neutralizing tests among FHV-1 isolates from many parts of the world and all have shown a homogeneity among the isolates (5, 8, 18, 25, 36) . The homogeneity was also confirmed by complement fixation, immunodiffusion, and hemagglutination inhibition tests (25, 38) . In cleavage patterns with several restriction endonucleases, small shifts in the electrophoretic mobilities of a few fragments were observed, but no remarkable change was detected (14, 16) . In spite of these facts, less virulent strains were developed and these strains have been used as vaccines without clear genomic markers (2-4, 10-12, 27, 30, 32-34, 39) . Recently, we compared a total of nine FHV-1 strains including the vaccine strain of F2 (3), the prototype strain of C27 (9) , and our laboratory strains of C7301 and C7805 (24) by immunoblot and restriction endonuclease analyses. The results showed that a viral structural protein with a molecular mass of 36 kDa was absent in the vaccine strain and that the cleavage patterns with restriction endonuclease MluI for the field isolates and a vaccine strain were different (17) . These results indicated that the absence of the 36-kDa protein and the specific MluI cleavage pattern might be used as markers for the vaccine F2 strain. Differentiation between field isolates and a vaccine strain appears to be of crucial importance, especially for evaluation of vaccine immunity. Moreover, a comparison of the properties of the vaccine strain with those of field isolates is necessary to characterize the less virulent virus for understanding FHV-1 pathogenesis in cats.
In this study, cleavage patterns found with restriction endonuclease MluI were further compared among 78 FHV-1 field isolates which were recently isolated from cats suspected to have feline viral rhinotracheitis in Japan from November 1990 to May 1991 (37) , and 4 additional strains, namely, F2, C7301, C27, and C7805, were used for the comparison. In addition, we compared the nucleotide sequences and transcriptional products of heterogeneous regions present in F2 and C7805 strains.
All isolates listed in Table 1 were propagated less than three times in Crandell feline kidney cell cultures. The cells were grown in Eagle's minimum essential medium (Nissui, Tokyo, Japan) containing 10% tryptose phosphate broth (Difco, Detroit, Mich.), 8% heat-inactivated fetal calf serum, and antibiotics. The maintenance medium for harvesting the virus was free of fetal calf serum. For extraction of DNAs, cells infected with each isolate were washed once with phosphate-buffered saline, lysed in 0.1 M Tris-HCl (pH 9.0) containing 1% sodium dodecyl sulfate, 0.1 M sodium chloride, and 1 mM EDTA, and then treated overnight with 1 mg of pronase E per ml at 37ЊC. DNAs were extracted with phenol, precipitated by ethanol, and then treated with the restriction endonuclease MluI. The digests were subjected to electrophoresis on a 0.5% agarose gel. Following electrophoresis, gels were stained with ethidium bromide and photographed on a UV light transilluminator. Figure 1 shows cleavage patterns with the MluI enzyme of 15 representative samples. Data for all isolates are summarized in Table 1 . The results suggested that three genotypes existed in FHV-1 isolates. The cleavage pattern of one genotype was similar to those of the C7301 and C27 strains. Both C27 and C7301 strains were very virulent against cats (9, 24) . This genotype (named the C7301 type) was found in 64 of the 78 field isolates. Seven of the nine strains of FHV-1 belonged to this type in the previous study (17) . The second genotype, including the F2 (vaccine) strain, lost two J (6.6-kbp) and L (2.5-kbp) fragments and gained one 9.1-kbp fragment. This group (named the F2 type) included eight isolates. The third genotype includes the C7805 strain which lost two H (7.0-kbp) and I (7.0-kbp) fragments and gained one 14.0-kbp fragment. This group (named the C7805 type) has only six strains. The C7805 strain was isolated from a cat suspected of having feline viral rhinotracheitis (17) . It is interesting to note that some field isolates belonging to the F2 type were obtained from both vaccinated and nonvaccinated cats. This result might imply two possibilities. The F2 strain might be recovered from either vaccinated cats or unvaccinated cats infected horizontally with To identify the regions of these heterogeneous MluI sites, purified DNA of the FHV-1 C7301 strain was extracted from virus particles, digested completely with MluI, blunted by T4 DNA polymerase, and then inserted into the EcoRV site of plasmid Bluescript SKϩ by T4 DNA ligase. We cloned several MluI fragments including the H, I, and J fragments. Next, we carried out Southern blot analysis by using these three fragments labeled with [ 32 P]dCTP as probes to identify their positions on the FHV-1 genome (data not shown). The results showed that the heterogeneous MluI sites absent in the F2 and C7805 types were located in a 4.3-kbp EcoRI fragment within the SalI-B fragment ( Fig. 2A and B) and a 5.5-kbp XbaI fragment within the 13.0-kbp SalI fragment (Fig. 2C) , respectively. However, we could not clearly identify the region of the 5.5-kbp XbaI fragment on the restriction map of the FHV-1 genome (31) .
Southern blot analysis was carried out to confirm the heterogeneity of the MluI sites within these fragments. Purified viral DNAs of F2, C7301, and C7805 strains were extracted from virus particles and digested with MluI. Figure 3 shows the electrophoretic pattern of the digested DNAs. After these DNAs were transferred to nylon sheets, hybridization was done by using 32 P-labeled 4.3-kbp EcoRI (Fig. 3A) and 5.5-kbp XbaI fragments (Fig. 3B) as the probes. The results confirmed that the two J and L fragments were lost, and only one band was detected in the F2 strain (Fig. 3A) . In the C7805 strain, the two H and I fragments were lost, and only one band was detected (Fig. 3B) . These results suggested that these fragments contained the heterogeneous MluI sites.
Northern (RNA) blot analysis was conducted to identify possible changes of products transcribed from these heterogeneous regions. Total RNAs were extracted from F2-, C7301-, C7805-, and mock-infected cells at 36 h postinfection by the method described previously (7) . Hybridization was done with the same probes used in Fig. 3 . However, no change was observed in mRNA transcribed from these heterogeneous regions (Fig. 4) .
Next, sequence analysis of the C7301 strain was carried out to determine the nucleotide sequences within these heterogeneous regions. At first, we mapped these EcoRI and XbaI fragments by using various restriction enzymes including MluI (Fig. 2) . The nucleotide sequence was extended by using Ampli Taq polymerase cycle sequencing kit (ABI, Foster City, Calif.) and then analyzed with a model 370A ABI autosequencer. (Fig. 5A) . The partial identities with the equine herpesvirus type 1 gI (13) and herpes simplex virus type 1 (HSV-1) gI (23) were 49.3 and 36.0%, respectively. To identify a mutation at the MluI site in the F2 strain, we designed two primers, 5Ј-TCTCCACAAGACCTC TATGC-3Ј and 5Ј-TCTTTCCATCGGTGATGGAG-3Ј, and then carried out PCR with these primers. The amplified fragment was cloned with the TA cloning kit (Invitrogen, San Diego, Calif.) and sequenced. This experiment was repeated three times to obtain exact sequence data for these PCR products. The result showed that only one mutation in the MluI site existed in the PCR products and generated a change from threonine to methionine in the predicted translation product. Although it is unknown whether this change influences virulence of the vaccine strain of F2, in vaccine strains of pseudorabies virus (PRV), the Bartha strain lacks gI (gE homolog) and gp63 (gI homolog) and the Norden strain lacks gI and has a partial deletion of gp63 (28) . It was reported that this gI counterpart interacts with the gE homologs in HSV-1 and PRV and that the interaction of PRV was thought to be necessary for the full expression of virulence (40) . Furthermore, Card et al. (6) demonstrated that the interaction in PRV influenced neurovirulence. Therefore, the mutation of the MluI site of the F2 type might be associated with the decreased virulence of FHV-1.
On the other hand, the nucleotide and predicted amino acid sequences around the MluI site within the XbaI fragment were highly homologous to U L 5 of HSV-1 (Fig. 5B) . The partial identity with the HSV-1 U L 5 gene was 52.0%. The translational product of the HSV-1 U L 5 gene was reported to be associated with viral DNA replication (22) . As for the F2 strain, we designed two primers, 5Ј-AAGAGACGTCACCTC CTGAT-3Ј and 5Ј-GGTTTCGTTGAGAGTCTGGA-3Ј, and sequenced this region of the C7805 strain. The result showed that two mutations in the amplified fragment of C7805 strain existed. However, it is unknown whether these changes of the C7805 strain are nonsense mutations, because there is no significant difference between the C7301 and C7805 strains in biological nature to our knowledge (17, 24, 25) . Further comparative analysis for translation products of the C7301 strain and the F2 or C7805 strain will be required.
So far, there has been no method that differentiates FHV-1 strains including the laboratory, field, and vaccine strains. However, it became possible to classify FHV-1 strains into at least three genotypes in this study. These genotypes might be useful for the epidemiological studies of FHV-1 infection which had been thought to be difficult to carry out. Furthermore, since it is possible to design primers to amplify these heterogeneous regions by the PCR method, it should be easier to differentiate FHV-1 field isolates by digesting the product with the MluI enzyme as previously reported for PRV (1, 15) .
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